+データを開く
-基本情報
登録情報 | データベース: PDB / ID: 1qg1 | ||||||
---|---|---|---|---|---|---|---|
タイトル | GROWTH FACTOR RECEPTOR BINDING PROTEIN SH2 DOMAIN COMPLEXED WITH AN SHC-DERIVED PEPTIDE | ||||||
要素 |
| ||||||
キーワード | HORMONE/GROWTH FACTOR / SIGNAL TRANSDUCTION / SH2 DOMAIN / PHOSPHOTYROSYL PEPTIDE / COMPLEX (SIGNAL TRANSDUCTION-PEPTIDE) / HORMONE-GROWTH FACTOR COMPLEX | ||||||
機能・相同性 | 機能・相同性情報 regulation of superoxide metabolic process / guanyl-nucleotide exchange factor adaptor activity / positive regulation of cell proliferation in bone marrow / Grb2-EGFR complex / branching involved in labyrinthine layer morphogenesis / XBP1(S) activates chaperone genes / STAT5 Activation / COP9 signalosome / neurotrophin TRKA receptor binding / Activated NTRK2 signals through PI3K ...regulation of superoxide metabolic process / guanyl-nucleotide exchange factor adaptor activity / positive regulation of cell proliferation in bone marrow / Grb2-EGFR complex / branching involved in labyrinthine layer morphogenesis / XBP1(S) activates chaperone genes / STAT5 Activation / COP9 signalosome / neurotrophin TRKA receptor binding / Activated NTRK2 signals through PI3K / MET receptor recycling / transmembrane receptor protein tyrosine kinase adaptor activity / Signaling by cytosolic FGFR1 fusion mutants / Interleukin-15 signaling / MET activates PTPN11 / MET activates RAP1 and RAC1 / Interleukin-2 signaling / vesicle membrane / Shc-EGFR complex / Costimulation by the CD28 family / CD28 dependent Vav1 pathway / Signaling by LTK / MET activates PI3K/AKT signaling / Signal regulatory protein family interactions / epidermal growth factor binding / natural killer cell mediated cytotoxicity / positive regulation of actin filament polymerization / epidermal growth factor receptor binding / Regulation of KIT signaling / Signaling by ALK / PI-3K cascade:FGFR2 / PI-3K cascade:FGFR3 / STAT5 activation downstream of FLT3 ITD mutants / PI-3K cascade:FGFR4 / PI-3K cascade:FGFR1 / endodermal cell differentiation / regulation of MAPK cascade / GRB2:SOS provides linkage to MAPK signaling for Integrins / RHOU GTPase cycle / PI3K events in ERBB2 signaling / PI3K Cascade / RET signaling / SOS-mediated signalling / insulin receptor substrate binding / Activated NTRK3 signals through RAS / Interleukin-3, Interleukin-5 and GM-CSF signaling / Activated NTRK2 signals through RAS / SHC1 events in ERBB4 signaling / fibroblast growth factor receptor signaling pathway / Signalling to RAS / signal transduction in response to DNA damage / RHO GTPases Activate WASPs and WAVEs / GAB1 signalosome / SHC-related events triggered by IGF1R / Activated NTRK2 signals through FRS2 and FRS3 / Role of LAT2/NTAL/LAB on calcium mobilization / Interleukin receptor SHC signaling / Signal attenuation / SHC-mediated cascade:FGFR2 / SHC-mediated cascade:FGFR3 / MET activates RAS signaling / Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants / Signaling by PDGFRA extracellular domain mutants / Schwann cell development / SHC-mediated cascade:FGFR4 / Signaling by FGFR4 in disease / Erythropoietin activates RAS / Signaling by CSF3 (G-CSF) / SHC-mediated cascade:FGFR1 / FRS-mediated FGFR2 signaling / FRS-mediated FGFR3 signaling / Signaling by FLT3 ITD and TKD mutants / Signaling by FGFR2 in disease / FRS-mediated FGFR4 signaling / Signaling by FGFR3 in disease / Tie2 Signaling / FRS-mediated FGFR1 signaling / insulin-like growth factor receptor binding / GRB2 events in EGFR signaling / FLT3 Signaling / SHC1 events in EGFR signaling / EGFR Transactivation by Gastrin / Signaling by FLT3 fusion proteins / phosphotyrosine residue binding / Signaling by FGFR1 in disease / myelination / ephrin receptor binding / GRB2 events in ERBB2 signaling / Integrin signaling / NCAM signaling for neurite out-growth / SHC1 events in ERBB2 signaling / Downstream signal transduction / Constitutive Signaling by Overexpressed ERBB2 / Insulin receptor signalling cascade / FCERI mediated Ca+2 mobilization / negative regulation of angiogenesis / insulin-like growth factor receptor signaling pathway / T cell activation / Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants / InlB-mediated entry of Listeria monocytogenes into host cell 類似検索 - 分子機能 | ||||||
生物種 | Homo sapiens (ヒト) | ||||||
手法 | 溶液NMR | ||||||
データ登録者 | Ogura, K. | ||||||
引用 | ジャーナル: J.Mol.Biol. / 年: 1999 タイトル: Solution structure of the SH2 domain of Grb2 complexed with the Shc-derived phosphotyrosine-containing peptide. 著者: Ogura, K. / Tsuchiya, S. / Terasawa, H. / Yuzawa, S. / Hatanaka, H. / Mandiyan, V. / Schlessinger, J. / Inagaki, F. | ||||||
履歴 |
|
-構造の表示
構造ビューア | 分子: MolmilJmol/JSmol |
---|
-ダウンロードとリンク
-ダウンロード
PDBx/mmCIF形式 | 1qg1.cif.gz | 49.2 KB | 表示 | PDBx/mmCIF形式 |
---|---|---|---|---|
PDB形式 | pdb1qg1.ent.gz | 35 KB | 表示 | PDB形式 |
PDBx/mmJSON形式 | 1qg1.json.gz | ツリー表示 | PDBx/mmJSON形式 | |
その他 | その他のダウンロード |
-検証レポート
文書・要旨 | 1qg1_validation.pdf.gz | 259.6 KB | 表示 | wwPDB検証レポート |
---|---|---|---|---|
文書・詳細版 | 1qg1_full_validation.pdf.gz | 259.3 KB | 表示 | |
XML形式データ | 1qg1_validation.xml.gz | 7.6 KB | 表示 | |
CIF形式データ | 1qg1_validation.cif.gz | 9.7 KB | 表示 | |
アーカイブディレクトリ | https://data.pdbj.org/pub/pdb/validation_reports/qg/1qg1 ftp://data.pdbj.org/pub/pdb/validation_reports/qg/1qg1 | HTTPS FTP |
-関連構造データ
-リンク
-集合体
登録構造単位 |
| |||||||||
---|---|---|---|---|---|---|---|---|---|---|
1 |
| |||||||||
NMR アンサンブル |
|
-要素
#1: タンパク質 | 分子量: 12012.516 Da / 分子数: 1 / 断片: SH2 / 由来タイプ: 組換発現 詳細: RESIDUES HIS-58 - THR-159 AND THE EXTRINSIC N-TERMINAL TWO RESIDUES, GLY-56 AND SER-57 由来: (組換発現) Homo sapiens (ヒト) / プラスミド: BL21 (DE3) 遺伝子 (発現宿主): PROTEIN WAS EXPRESSED WITH PGEX-4T-2 VECTOR AND BL21 (DE3) CELL AS GST-FUSION PROTEIN, AND CLEAVED WITH TRYPSIN 発現宿主: Escherichia coli (大腸菌) / 参照: UniProt: P62993 |
---|---|
#2: タンパク質・ペプチド | 分子量: 1587.558 Da / 分子数: 1 / 断片: 423-435 / 由来タイプ: 合成 詳細: THE PEPTIDE WAS CHEMICALLY SYNTHESIZED BY THE SOLID-PHASE FMOC STRATEGY. THE SEQUENCE OF THIS PEPTIDE IS NATURALLY FOUND IN HOMO SAPIENS (HUMAN). 参照: UniProt: P29353 |
-実験情報
-実験
実験 | 手法: 溶液NMR |
---|---|
NMR実験の詳細 | Text: MEAN STRUCTURE. NULL |
-試料調製
試料状態 | pH: 6.3 / 温度: 301 K |
---|---|
結晶化 | *PLUS 手法: other / 詳細: NMR |
-解析
NMR software |
| ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NMRアンサンブル | コンフォーマー選択の基準: LOWEST ENERGY / 計算したコンフォーマーの数: 100 / 登録したコンフォーマーの数: 1 |